权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Genomic integrity of the X chromosome and Ovary-Specific Autosomal Gene

X 染色体和卵巢特异性常染色体基因的基因组完整性

基本信息

批准号：
8604054
负责人：
ALEKSANDAR RAJKOVIC
金额：
$ 21.15万
依托单位：
MAGEE-WOMEN'S RES INST AND FOUNDATION
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-05-01 至 2016-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8604054
关键词：
Affect Age Animal Model BMP15 gene Base Pairing Basic Science Biological Markers Biological Preservation Candidate Disease Gene Cardiovascular Diseases Cardiovascular system Clinical Clinical Data Custom Cytogenetics DNA Sequence Rearrangement Data Development Diagnosis Early Intervention Etiology FMR1 Failure Female Fertility Future Gene Dosage Genes Genetic Genetic Markers Genetic Predisposition to Disease Genomics Guidelines Health Human Individual Infertility Investigation Karyotype Lead Longevity Massive Parallel Sequencing Medical Morbidity - disease rate Mosaicism Mutation Osteoporosis Ovarian Ovary Participant Pathologic Pathway interactions Personal Satisfaction Physiologic calcification Play Predisposition Premature Ovarian Failure Primordial Follicle Reproduction Research Resolution Risk Role Sex Chromosomes Testing Time Turner&apos s Syndrome Variant Woman X Chromosome base body system clinical practice cohort defined contribution design exome interest knockout animal male microdeletion mortality novel ovarian failure premature psychosocial public health relevance reproductive therapy design

项目摘要

Abstract Primordial follicle pool depletion is the cause of primary ovarian insufficiency (POI) in most women. POI afflicts 1-2% of women, and genetics contributes as much as 70% to POI. Besides infertility, women with POI are at increased risk for osteoporosis, cardiovascular morbidity and mortality. Currently only karyotype and FMR1 pre-mutation testing are offered to women with POI. Fertility preservation is currently feasible for women at risk for losing ovarian function, yet there is a great need for robust and better biomarkers capable of predicting ovarian insufficiency. We are interested in identifying genetic biomarkers that associate with POI. The role of the X chromosome and candidate autosomal genes implicated from knockout animal models has been hypothesized for a long time in the etiology of human POI, yet there is little to show at the gene level. We constructed a novel high-resolution genomic array that interrogates the X chromosome and 134 candidate autosomal gene copy numbers. We show that this array can detect genomic imbalances as small as 500 base pairs, and is superior to commercial arrays. We hypothesize that pathologic genomic imbalances involving the X chromosome and candidate autosomal loci, will be present in more than 10% of women who suffer POI. Moreover, we will sequence the X-chromosome exomes, as well as the exomes of 134 candidate autosomal genes to define contribution of pathogenic mutations to POI. Our proposal will test the relevance of our targeted approach in identifying pathogenic mutations in women with POI, and will stimulate further research into the feasibility of such targeted approaches to predict ovarian failure. Proposed studies may identify novel pathways, and provide future directions for basic science investigations relevant to human POI.

摘要